Avian Metapneumovirus Treatment Market

Future Market Insights

Avian Metapneumovirus Treatment Market

Key Insight

The avian metapneumovirus treatment market is projected to grow from USD 311.6 million in 2025 to USD 579.5 million by 2035, exhibiting a robust CAGR of 6.4% between 2025 and 2035. By treatment, vaccines segment accounts for over 68.4% share and commercial poultry farms dominate sales channel segment with 62.6% share in 2025.

July 02, 2025

Anurag Sharma

250 Pages

Cite this Report

Avian Metapneumovirus Treatment Market

https://www.futuremarketinsights.com/reports/avian-metapneumovirus-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

AdvaCare Pharma
Ashish Life Science
Boehringer Ingelheim Animal Health
CEVA ANIMAL HEALTH LLC
HIPRA
Merck KGaA
Phibro Animal Health Corporation
Virbac

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Avian Metapneumovirus Treatment Market

Key Players

Similar Industry Reports